![](/img/cover-not-exists.png)
Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 trial
Shen, Qiu-Dan, Zhu, Hua-Yuan, Wang, Li, Fan, Lei, Liang, Jin-Hua, Cao, Lei, Wu, Wei, Xia, Yi, Li, Jian-Yong, Xu, WeiLanguage:
english
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(18)30054-1
Date:
May, 2018
File:
PDF, 711 KB
english, 2018